Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
GMRE 
Global Medical REIT Inc (GMRE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/30/2025: GMRE (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $44.42
1 Year Target Price $44.42
| 4 | Strong Buy |
| 1 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -16.72% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 836.00M USD | Price to earnings Ratio 87.71 | 1Y Target Price 44.42 |
Price to earnings Ratio 87.71 | 1Y Target Price 44.42 | ||
Volume (30-day avg) 10 | Beta 1.22 | 52 Weeks Range 28.88 - 42.60 | Updated Date 10/31/2025 |
52 Weeks Range 28.88 - 42.60 | Updated Date 10/31/2025 | ||
Dividends yield (FY) 12.58% | Basic EPS (TTM) 0.35 |
Earnings Date
Report Date 2025-11-05 | When - | Estimate 0.0033 | Actual - |
Profitability
Profit Margin 7.25% | Operating Margin (TTM) 23.61% |
Management Effectiveness
Return on Assets (TTM) 1.67% | Return on Equity (TTM) 1.93% |
Valuation
Trailing PE 87.71 | Forward PE 232.56 | Enterprise Value 1240709941 | Price to Sales(TTM) 5.89 |
Enterprise Value 1240709941 | Price to Sales(TTM) 5.89 | ||
Enterprise Value to Revenue 8.76 | Enterprise Value to EBITDA 12.74 | Shares Outstanding 13407409 | Shares Floating 12584169 |
Shares Outstanding 13407409 | Shares Floating 12584169 | ||
Percent Insiders 5.89 | Percent Institutions 69.5 |
Upturn AI SWOT
Global Medical REIT Inc
Company Overview
History and Background
Global Medical REIT Inc. was founded in 2012, becoming a publicly traded REIT in 2016 (NYSE: GMRE). It focuses on acquiring and leasing medical properties, building a portfolio of outpatient healthcare facilities.
Core Business Areas
- Real Estate Investments: Acquisition, leasing, and management of medical office buildings, rehabilitation facilities, specialty clinics, and other healthcare-related properties.
Leadership and Structure
Jeffrey M. Busch is the Chief Executive Officer. The company operates under a REIT structure, managed by a board of directors.
Top Products and Market Share
Key Offerings
- Medical Office Buildings: GMRE primarily invests in medical office buildings leased to physicians, hospitals, and healthcare systems. Market share is fragmented, relying on individual transaction size and availability. Competitors include Healthcare Trust of America (HTA), Physicians Realty Trust (DOC) and Medical Properties Trust (MPW).
- Outpatient Healthcare Facilities: The company also invests in other outpatient facilities such as rehabilitation centers and specialty clinics. The market share depends on the location and regional competition with various private and public healthcare providers. Competitors include Healthcare Trust of America (HTA), Physicians Realty Trust (DOC) and Medical Properties Trust (MPW).
Market Dynamics
Industry Overview
The medical office building (MOB) market is growing, driven by an aging population and the shift towards outpatient care. The industry is somewhat recession-resistant due to consistent healthcare demand.
Positioning
GMRE is a smaller player compared to larger healthcare REITs. Its strategy focuses on acquiring properties in secondary and tertiary markets. This helps them find higher cap rates.
Total Addressable Market (TAM)
The US healthcare real estate market is estimated to be in the hundreds of billions of dollars. GMRE's positioning allows them to capitalize on a portion of this TAM, focusing on strategically acquired assets.
Upturn SWOT Analysis
Strengths
- Focus on medical properties provides stable cash flow
- Acquisition strategy in secondary and tertiary markets yields higher returns
- Experienced management team in healthcare real estate
- Diversified portfolio across multiple states
Weaknesses
- Smaller market capitalization compared to larger REITs
- Concentration risk in certain geographic areas
- Vulnerability to changes in healthcare regulations
- Higher cost of capital than larger REITs
Opportunities
- Further consolidation of the fragmented medical property market
- Expansion into new healthcare subsectors (e.g., urgent care centers)
- Strategic partnerships with healthcare systems
- Rising demand for outpatient healthcare services
Threats
- Rising interest rates
- Economic downturn affecting healthcare spending
- Increased competition from larger REITs
- Changes in healthcare reimbursement policies
Competitors and Market Share
Key Competitors
- HTA
- DOC
- MPW
Competitive Landscape
GMRE is smaller than its major competitors. Its advantages include a focus on secondary markets and a nimble acquisition strategy. Disadvantages include higher cost of capital and less brand recognition than larger REITs. The market share is estimated and highly subject to change. There is a large percentage of the market with companies which own less than 1% of the market. The market share represents the healthcare REIT market.
Major Acquisitions
MCORE
- Year: 2018
- Acquisition Price (USD millions): 77.7
- Strategic Rationale: Expanded GMRE's portfolio and geographic footprint.
Growth Trajectory and Initiatives
Historical Growth: GMRE's historical growth has been driven by strategic acquisitions of medical properties. The growth rate has fluctuated based on market conditions and available investment opportunities.
Future Projections: Future growth projections are subject to analyst estimates and market conditions. Consult financial news and analyst reports for specific projections.
Recent Initiatives: Recent initiatives typically involve acquisitions, property development, and capital management strategies. Check their latest press releases for the current plans.
Summary
Global Medical REIT is a smaller healthcare REIT focused on secondary markets, offering a unique investment proposition. Its strategic acquisitions drive growth, but it faces competition from larger REITs and exposure to interest rate risk. The company's focus on medical properties provides stable cash flow, although its smaller size and concentration risks must be considered. It needs to be careful that large tenants do not create concentration risk.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q)
- Investor Presentations
- Press Releases
- Market Research Reports
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Data may be outdated and should be independently verified. Investment decisions should be made based on thorough research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Global Medical REIT Inc
Exchange NYSE | Headquaters Bethesda, MD, United States | ||
IPO Launch date 2016-06-29 | President, CEO & Director Mr. Mark O. Decker Jr. | ||
Sector Real Estate | Industry REIT - Healthcare Facilities | Full time employees 26 | |
Full time employees 26 | |||
GMRE is a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.